Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

An Online Lifestyle Modification Course for People With Multiple SclerosisUnknown
NCT05374473NAUpdated Dec 12, 2023
Sponsor: University of Melbourne
Multiple Sclerosis
Australia
The Effect of the Nurses Support Program on Fatigue in MS PatientUnknown
NCT06166043NAUpdated Dec 12, 2023
Sponsor: Istanbul University - Cerrahpasa
Multiple Sclerosis · Fatigue · Sleep Hygiene · Quality of Life
Turkey (Türkiye)
Ocrelizumab Effects on the Metabolome in MSCompleted
NCT03873389N/AUpdated Dec 12, 2023
Sponsor: Johns Hopkins University
Multiple Sclerosis
United States
Evaluation of the Presence and Effects of Kinesiophobia in Multiple SclerosisCompleted
NCT06167447N/AUpdated Dec 12, 2023
Sponsor: Gazi University
Multiple Sclerosis · Kinesiophobia
Turkey (Türkiye)
Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple SclerosisUnknown
NCT05809414Phase 3Updated Dec 11, 2023
Sponsor: Hospital San Carlos, Madrid
Multiple Sclerosis · Fatigue
Spain
A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple SclerosisCompleted
NCT04626921Phase 2, Phase 3Updated Dec 8, 2023
Sponsor: Clene Nanomedicine
Relapsing Multiple Sclerosis
Australia
The Effects of Action Observation Therapy (AOT) on Balance and Gait in Patients With Multiple Sclerosis.Unknown
NCT05543213NAUpdated Dec 7, 2023
Sponsor: Shiraz University of Medical Sciences
Multiple Sclerosis
Iran
Comparative Study of High-Efficacy Disease Modifying Treatment of Relapsing Multiple SclerosisUnknown
NCT06159712NAUpdated Dec 7, 2023
Sponsor: University of Aarhus
Relapsing Remitting Multiple Sclerosis
Denmark
CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple SclerosisCompleted
NCT05671055N/AUpdated Dec 7, 2023
Sponsor: icometrix
Multiple Sclerosis
United States, Belgium, Germany
Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple SclerosisTerminated
NCT04203017Phase 1Updated Dec 6, 2023
Sponsor: St. Petersburg State Pavlov Medical University
Multiple Sclerosis
Russia
Exploring Accessible Beauty for Individuals With Upper Extremity DeficitsCompleted
NCT05945784N/AUpdated Dec 6, 2023
Sponsor: Casa Colina Hospital and Centers for Healthcare
Stroke, Ischemic · Stroke Hemorrhagic · Stroke (CVA) or TIA · Stroke, Acute
United States
Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMSUnknown
NCT05510817NAUpdated Dec 5, 2023
Sponsor: University Hospital of Mont-Godinne
Multiple Sclerosis, Relapsing-Remitting
Belgium
Artificial Intelligence in Predicting Progression in Multiple Sclerosis StudyCompleted
NCT05426980N/AUpdated Dec 5, 2023
Sponsor: University of Ljubljana
Multiple Sclerosis · Multiple Sclerosis Lesion · Multiple Sclerosis Brain Lesion
Slovenia
Strengthening Mental Abilities With Relational Training (SMART) in Multiple Sclerosis (MS): A Feasibility TrialUnknown
NCT04975685NAUpdated Dec 5, 2023
Sponsor: University of Lincoln
Multiple Sclerosis
United Kingdom
Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MSCompleted
NCT03799718Phase 2Updated Dec 4, 2023
Sponsor: Brainstorm-Cell Therapeutics
Multiple Sclerosis, Chronic Progressive
United States
Non-invasive Transcranial Electrical Stimulation in MSCompleted
NCT04466228NAUpdated Dec 4, 2023
Sponsor: University of California, San Francisco
Multiple Sclerosis · Cognitive Impairment
United States
Development of a Telehealth Obesity Intervention for Patients With MS: Modifying Diet and Exercise in MSCompleted
NCT04255953NAUpdated Nov 30, 2023
Sponsor: Jared Bruce
Multiple Sclerosis · Obesity
United States
Validation of a Novel Instrument Task for Assessing Upper LimbCompleted
NCT04868370N/AUpdated Nov 29, 2023
Sponsor: Swiss Federal Institute of Technology
Assessment of Arm and Hand Sensorimotor Functions in Multiple Sclerosis Subjects
Switzerland
Studies in Patients With Tuberous Sclerosis ComplexCompleted
NCT03276195N/AUpdated Nov 29, 2023
Sponsor: Translational Genomics Research Institute
Tuberous Sclerosis Complex
United States
Effectiveness of Dry Needling for Improving Gait in the Patient With Multiple SclerosisCompleted
NCT05956119NAUpdated Nov 29, 2023
Sponsor: Hospital Universitario de Canarias
Multiple Sclerosis
Spain
Multiple Sclerosis Pelvic Floor TelerehabilitationCompleted
NCT05984095NAUpdated Nov 28, 2023
Sponsor: University of Trieste
Multiple Sclerosis
Italy
Outcomes of Group Dance and Movement Training in Ambulatory MS PatientsCompleted
NCT05943145NAUpdated Nov 28, 2023
Sponsor: GroundWorks DanceTheater
Multiple Sclerosis
United States
A Study of MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)Terminated
NCT04948554Phase 1Updated Nov 24, 2023
Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Systemic Sclerosis With and Without Interstitial Lung Disease
United States, Canada, Italy, Switzerland
A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker DiscoveryCompleted
NCT01592552N/AUpdated Nov 22, 2023
Sponsor: Sanguine Biosciences
Alzheimer's Disease · Multiple Sclerosis · Parkinson's Disease · Huntington's Disease
United States
Blood Flow Restriction Training in Multiple SclerosisUnknown
NCT06143930NAUpdated Nov 22, 2023
Sponsor: Cairo University
MS
Egypt

Previous page Next page